相关实验视频
Updated: Jun 17, 2026

08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
黄类药物和多囊性卵巢综合征
1Medical College, Guangxi University, Nanning, Guangxi, 530004, China. liuyu@gxu.edu.cn.
Food & function
|February 19, 2026
概括
黄类药物为多囊卵巢综合征 (PCOS) 提供了有前途的自然疗法,减少炎症并改善代谢健康. 这些植物化合物显示出与传统治疗相比,更安全的PCOS管理的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多囊卵巢综合征 (PCOS) 是一种复杂的内分泌疾病,影响女性的生殖和代谢健康.
- 目前的PCOS治疗方法,如COCPs和美特福林,具有局限性和不良影响.
- 对于PCOS管理来说,急需更安全,更耐受的治疗替代方案.
研究的目的:
- 系统地审查关于黄类药物在治疗PCOS中的疗效的临床前和临床证据.
- 阐明在PCOS中黄类药物的治疗作用背后的分子机制.
- 总结PCOS患者的内分泌和代谢参数的改善,这些患者接受了黄类药物治疗.
主要方法:
- 在PCOS模型中对临床前研究进行系统审查.
- 对临床试验的分析,研究了PCOS患者的黄类补充剂.
- 对分子通路的检查,包括Nrf2,NF-κB,NLRP3炎症体和AMPK信号的检查.
主要成果:
- 黄类药物通过Nrf2激活和NF-κB/NLRP3抑制来缓解PCOS相关的氧化应激和炎症.
- 临床前研究表明,黄类药物降低血清雌激素和胰岛素,并改善卵巢形态.
- 临床试验表明,奎尔素,大豆异黄和素可以改善PCOS内分泌/代谢标志物和卵细胞质量.
结论:
- 黄类药物为PCOS提供了可行的治疗策略,解决了关键的病理特征.
- 通过特定的信号通路介导的黄类的抗炎和抗氧化性质对于它们的有效性至关重要.
- 黄酸是一种有希望的,自然的方法来改善PCOS症状和患者的治疗结果.
相关概念视频
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

